ATP11B and lung adenocarcinoma: In addition, ATP11B is significantly upregulated in PDAC and lung squamous cell carcinoma and its high expression is associated with a lower survival rate in patients with adrenocortical carcinoma, acute myeloid leukemia, brain lower grade glioma, lung adenocarcinoma, and PDAC.